跳至主要内容
临床试验/TCTR20230417002
TCTR20230417002尚未招募4 期

The efficacy and safety of Fractional Erbium:YAG assisting percutaneous absorption of triamcinolone acetonide in different dosage forms : A pilot Study

Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 6 人开始时间: 2023年4月17日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
6

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • 1. Healthy Thai descendant
  • 2. Have healthy skin, i.e., the skin on the forearm is free of inflammation, infection, and dyspigmentation.
  • 3. Patients who voluntarily agree to participate in the study

排除标准

  • 1. Being pregnant, breastfeeding, or after giving birth for no more than 3 months
  • 2. Have open wounds, scars, infections or tattoos on the forearm
  • 3. Perform any skin treatment (e.g., tanning, laser) on the forearm within 4 weeks prior to the start of the study.
  • 4. Have a history of allergy to steroids
  • 5. Have photosensitive rash or sensitivity to light
  • 6. Have a history of using substances that affect wound healing, such as using steroids or smoking regularly

研究者

发起方
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University

相似试验

The efficacy and safety of Fractional Erbium:YAG... | 临床试验